Combating malaria has been one of the primary goals of the Bill and Melinda Gates Foundation, and its latest gift of $42.6 million will fund a nonprofit drug company’s high-tech take on an ancient Chinese remedy.
Working with a biotechnology company, the San Francisco-based Institute for OneWorld Health will try to turn the genetic engineering efforts of Jay Keasling of the University of California, Berkley into an inexpensive and effective drug to fight malaria in the third world. An announcement was expected Monday. Keasling is developing a new way to manufacture artemisinin, which is made from finely ground wormwood plants.
Read the rest here
Good job Billg!